JP2024540199A5 - - Google Patents
Info
- Publication number
- JP2024540199A5 JP2024540199A5 JP2024525780A JP2024525780A JP2024540199A5 JP 2024540199 A5 JP2024540199 A5 JP 2024540199A5 JP 2024525780 A JP2024525780 A JP 2024525780A JP 2024525780 A JP2024525780 A JP 2024525780A JP 2024540199 A5 JP2024540199 A5 JP 2024540199A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- light chain
- seq
- heavy chain
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274306P | 2021-11-01 | 2021-11-01 | |
| US63/274,306 | 2021-11-01 | ||
| PCT/US2022/078975 WO2023077120A1 (en) | 2021-11-01 | 2022-10-31 | Muscle targeting complexes for treating dystrophinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540199A JP2024540199A (ja) | 2024-10-31 |
| JP2024540199A5 true JP2024540199A5 (https=) | 2026-01-19 |
Family
ID=86158573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525780A Pending JP2024540199A (ja) | 2021-11-01 | 2022-10-31 | ジストロフィノパチーを処置するための筋標的化複合体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4426356A1 (https=) |
| JP (1) | JP2024540199A (https=) |
| KR (1) | KR20240095330A (https=) |
| CN (1) | CN118201640A (https=) |
| AU (1) | AU2022377070A1 (https=) |
| CA (1) | CA3233308A1 (https=) |
| IL (1) | IL312142A (https=) |
| MX (1) | MX2024005332A (https=) |
| WO (1) | WO2023077120A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202100928QA (en) | 2018-08-02 | 2021-02-25 | Dyne Therapeutics Inc | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| CA3108282A1 (en) | 2018-08-02 | 2020-02-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| JP2024525608A (ja) | 2021-07-09 | 2024-07-12 | ダイン セラピューティクス，インコーポレーテッド | ジストロフィン異常症を処置するための筋標的化複合体および製剤 |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| IL316143A (en) | 2022-04-15 | 2024-12-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012157167A (ru) * | 2010-07-12 | 2014-08-20 | КовЭкс Текнолоджиз Айэлэнд Лимитед | Полифункциональные антительные конъюгаты |
| EP3447071A1 (en) * | 2012-01-09 | 2019-02-27 | Pfizer Healthcare Ireland | Mutant antibodies and conjugation thereof |
| US10758607B2 (en) * | 2015-06-17 | 2020-09-01 | The Research Institute At Nationwide Children's Hospital | Respiratory syncytial virus having cleavage-resistant G protein and related materials and methods |
| MD3464306T2 (ro) * | 2016-05-24 | 2024-08-31 | Sarepta Therapeutics Inc | Procedee de preparare a oligomerilor morfolino fosforodiamidați |
| US20200155702A1 (en) * | 2017-06-16 | 2020-05-21 | Eli Lilly And Company | Engineered Antibody Compounds and Conjuates Thereof |
| KR20220125801A (ko) * | 2020-01-10 | 2022-09-14 | 다인 세라퓨틱스, 인크. | 근육 표적화 복합체 및 안면견갑상완 근육 이영양증을 치료하기 위한 그의 용도 |
-
2022
- 2022-10-31 AU AU2022377070A patent/AU2022377070A1/en active Pending
- 2022-10-31 CN CN202280073596.0A patent/CN118201640A/zh active Pending
- 2022-10-31 KR KR1020247018073A patent/KR20240095330A/ko active Pending
- 2022-10-31 IL IL312142A patent/IL312142A/en unknown
- 2022-10-31 EP EP22888561.2A patent/EP4426356A1/en active Pending
- 2022-10-31 JP JP2024525780A patent/JP2024540199A/ja active Pending
- 2022-10-31 CA CA3233308A patent/CA3233308A1/en active Pending
- 2022-10-31 MX MX2024005332A patent/MX2024005332A/es unknown
- 2022-10-31 WO PCT/US2022/078975 patent/WO2023077120A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540199A5 (https=) | ||
| JP2023510350A5 (https=) | ||
| IL320340A (en) | Muscle targeting complexes and uses thereof for skipping exon 45 of a dmd gene | |
| IL312142A (en) | Muscle targeting complexes for the treatment of dystrophinopathy | |
| JP2024527362A5 (https=) | ||
| IL309936A (en) | Muscle targeting complexes and formulations for the treatment of dystrophinopathy | |
| JP2025512469A5 (https=) | ||
| JP2024525610A5 (https=) | ||
| JP2024534488A5 (https=) | ||
| JP2024525611A5 (https=) | ||
| JP2024525613A5 (https=) | ||
| IL311507A (en) | Dosing of muscle targeting complexes for the treatment of dystrophinopathy | |
| JP2023535073A5 (https=) | ||
| JP7041516B2 (ja) | 共通軽鎖を有する二重特異性抗体又は抗体混合物 | |
| IL315944A (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| JP2023509793A5 (https=) | ||
| JP2021532831A5 (https=) | ||
| JP7663977B2 (ja) | 抗ｐｄ―ｌ１抗体およびその用途 | |
| JP2025512468A5 (https=) | ||
| JP2024524222A5 (https=) | ||
| IL316143A (en) | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy | |
| IL309912A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| JP2012504401A5 (https=) | ||
| RU2011115559A (ru) | Антитела к cxcr4 и их применение для лечения рака | |
| JP2006506955A5 (https=) |